Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín, Katayoun Rezvani, Vakul Mohanty et al.|Nature Medicine|2024Cited by 452
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemiaNatalia Baran, Joseph R. Marszalek, Alessia Lodi et al.|Nature Communications|2022Cited by 63
Overcoming NOTCH1-Driven Chemoresistance in T-Cell Acute Lymphoblastic Leukemia Via Metabolic Intervention with Oxphos InhibitorNatalia Baran, Marina Konopleva, Alessia Lodi et al.|Blood|2020Cited by 6